BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20932764)

  • 1. Comment on "Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke".
    Ahmad A; Sharma VK
    J Clin Neurosci; 2011 Jan; 18(1):160-1; author reply 161. PubMed ID: 20932764
    [No Abstract]   [Full Text] [Related]  

  • 2. IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon?
    Barrett KM; Gottesman RF
    Neurology; 2016 Jul; 87(2):132-3. PubMed ID: 27306635
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke.
    Zhou XY; Wang SS; Collins ML; Davis SM; Yan B
    J Clin Neurosci; 2010 Aug; 17(8):988-92. PubMed ID: 20510615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolysis in patients older than age 80 years.
    Longstreth WT; Tirschwell DL
    Stroke; 2010 Oct; 41(10):e580; author reply e581. PubMed ID: 20798362
    [No Abstract]   [Full Text] [Related]  

  • 6. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
    Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients.
    Chao AC; Liu CK; Chen CH; Lin HJ; Liu CH; Jeng JS; Hu CJ; Chung CP; Hsu HY; Sheng WY; Hu HH;
    Stroke; 2014 Aug; 45(8):2359-65. PubMed ID: 24994721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of a modified intravenous recombinant tissue plasminogen activator regimen in Chinese patients with acute ischemic stroke.
    Pan SM; Liu JF; Liu M; Shen S; Li HJ; Dai LH; Chen XJ
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):690-3. PubMed ID: 23111010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW
    Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial Infarction Following Intravenous Thrombolysis for Acute Ischemic Stroke: Case Report and Literature Review.
    Mannino M; Asciutto S; Terruso V; Gammino M; Cellura MG; Monaco S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e105-e107. PubMed ID: 28434774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S; Wada K; Nagatani K; Otani N; Osada H; Nawashiro H
    Acta Neurochir (Wien); 2012 Jan; 154(1):87. PubMed ID: 22037979
    [No Abstract]   [Full Text] [Related]  

  • 13. Bridging therapy in acute ischemic stroke: are we ready for a new standard of care?
    Mazighi M; Labreuche J
    Stroke; 2011 Apr; 42(4):880-1. PubMed ID: 21372303
    [No Abstract]   [Full Text] [Related]  

  • 14. Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke.
    Yip TR; Demaerschalk BM
    Neurocrit Care; 2005; 2(1):47-8. PubMed ID: 16174968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke.
    Loh PK; Sharma VK
    Stroke; 2010 Mar; 41(3):e164; author reply 165. PubMed ID: 20110536
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X; George MG; Yang Q; Gillespie C
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digestive and urologic hemorrhage after intravenous thrombolysis for acute ischemic stroke: Data from a Chinese stroke center.
    Chang H; Wang X; Yang X; Song H; Qiao Y; Liu J
    J Int Med Res; 2017 Feb; 45(1):352-360. PubMed ID: 28222621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban.
    van Hooff RJ; Nieboer K; De Smedt A; Yperzeele L; Jochmans K; De Keyser J; Brouns R
    Clin Neurol Neurosurg; 2014 Jul; 122():133-4. PubMed ID: 24813326
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis.
    Kamal H; Mowla A; Farooq S; Shirani P
    J Neurol Sci; 2015 Nov; 358(1-2):496-7. PubMed ID: 26375625
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.